France-based vision technology developer Prophesee confirmed today it has completed a $28m financing round that included industrial technology and appliance producer Robert Bosch’s corporate venturing subsidiary, Robert Bosch Venture Capital (RBVC).
The multilateral European Investment Bank led the round, which was also backed by healthcare technology investment firm iBionext, venture capital fund 360 Capital Partners and VC fund manager Supernova Invest.
Founded as Chronocam, Prophesee is developing neuromorphic vision systems that are modelled after the interaction between the human eye and brain. They are intended to enhance vision technology in areas like security, surveillance, autonomous vehicles, augmented and virtual reality.
The round’s closure follows the company’s release of Metavision, an event-ready sensor for use in machine vision systems in which each pixel activates itself in response to the contrast in other pixels that is triggered by movement.
Luca Verre, Prophesee’s co-founder and chief executive, said: “This latest round of financing will help us move rapidly from these successes to broader market adoption.”
Prophesee has now secured $68m altogether. RBVC joined CEA Investissement to supply $950,000 in funding in 2015 after the company had been seeded by iBionext the year before.
Semiconductor and data technology company Intel led a $15m round for Prophesee in 2016 through its Intel Capital unit, investing alongside RBVC, automotive manufacturer Renault, CEA Investissement, iBionext and 360 Capital.
Renault, RBVC and Intel Capital returned to provide $19m in series B funding for the company in February 2018 together with 360 Capital Partners, Supernova Invest and iBionext’s Growth Fund.
Image courtesy of Prophesee.
